March 14, 2013 – FDA announces that it is investigating the risk of pancreatitis, pancreatic cancer with Victoza and other incretin mimetic diabetes drugs.
March 14, 2013 – FDA announces that it is investigating the risk of pancreatitis, pancreatic cancer with Victoza and other incretin mimetic diabetes drugs.